The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098
- Solomon, Scott D.
- McMurray, John J.V.
- Claggett, Brian
- de Boer, Rudolf A.
- DeMets, David
- Hernandez, Adrian F.
- Inzucchi, Silvio E.
- Kosiborod, Mikhail N.
- Lam, Carolyn S.P.
- Martinez, Felipe
- Shah, Sanjiv J.
- Desai, Akshay S.
- Jhund, Pardeep S.
- Belohlavek, Jan
- Chiang, Chern-En
- Borleffs, C. Jan Willem
- Comin-Colet, Josep
- Dobreanu, Dan
- Drozdz, Jaroslaw
- Fang, James C.
- Alcocer-Gamba, Marco Antonio
- Al Habeeb, Waleed
- Han, Yaling
- Cabrera Honorio, Jose Walter
- Janssens, Stefan P.
- Katova, Tzvetana
- Kitakaze, Masafumi
- Merkely, Béla
- O’Meara, Eileen
- Saraiva, Jose Francisco Kerr
- Tereshchenko, Sergey N.
- Thierer, Jorge
- Vaduganathan, Muthiah
- Vardeny, Orly
- Verma, Subodh
- Pham, Vinh Nguyen
- Wilderäng, Ulrica
- Zaozerska, Natalia
- Bachus, Erasmus
- Lindholm, Daniel
- Petersson, Magnus
- Langkilde, Anna Maria
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Solomon, Scott D.
- McMurray, John J.V.
- Claggett, Brian
- de Boer, Rudolf A.
- DeMets, David
- Hernandez, Adrian F.
- Inzucchi, Silvio E.
- Kosiborod, Mikhail N.
- Lam, Carolyn S.P.
- Martinez, Felipe
- Shah, Sanjiv J.
- Desai, Akshay S.
- Jhund, Pardeep S.
- Belohlavek, Jan
- Chiang, Chern-En
- Borleffs, C. Jan Willem
- Comin-Colet, Josep
- Dobreanu, Dan
- Drozdz, Jaroslaw
- Fang, James C.
- Alcocer-Gamba, Marco Antonio
- Al Habeeb, Waleed
- Han, Yaling
- Cabrera Honorio, Jose Walter
- Janssens, Stefan P.
- Katova, Tzvetana
- Kitakaze, Masafumi
- Merkely, Béla
- O’Meara, Eileen
- Saraiva, Jose Francisco Kerr
- Tereshchenko, Sergey N.
- Thierer, Jorge
- Vaduganathan, Muthiah
- Vardeny, Orly
- Verma, Subodh
- Pham, Vinh Nguyen
- Wilderäng, Ulrica
- Zaozerska, Natalia
- Bachus, Erasmus
- Lindholm, Daniel
- Petersson, Magnus
- Langkilde, Anna Maria
- Titel
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- Ist Teil von
- The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Quelle
- Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
- Beschreibungen/Notizen
- In a trial involving patients with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the risk of worsening heart failure or cardiovascular death.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2206286Titel-ID: cdi_swepub_primary_oai_DiVA_org_uu_512691
- Format
- –
- Schlagworte
- Antidiabetics, Benzhydryl Compounds - adverse effects, Benzhydryl Compounds - therapeutic use, Benzhydryl Compounds/adverse effects/therapeutic use, Cardiology, Cardiology General, Congestive heart failure, Coronaviruses, COVID-19, Death, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2 - complications, Diabetes Mellitus, Type 2 - drug therapy, Disease prevention, Ejection fraction, Glucosides - adverse effects, Glucosides - therapeutic use, Glucosides/adverse effects/therapeutic use, Heart Failure, Heart Failure - complications, Heart Failure - drug therapy, Heart Failure - mortality, Heart Failure - physiopathology, Heart Failure/complications/drug therapy/mortality/physiopathology, Hospitalization, Humans, Inhibitor drugs, Left/drug effects, Placebos, Sodium-glucose cotransporter, Sodium-Glucose Transporter 2 Inhibitors - adverse effects, Sodium-Glucose Transporter 2 Inhibitors - pharmacology, Sodium-Glucose Transporter 2 Inhibitors - therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects/pharmacology/therapeutic use, Stroke Volume - drug effects, Type 2/complications/drug therapy, Ventricle, Ventricular Function, Ventricular Function, Left - drug effects